PROTACS – A New Generation of Poorly Soluble and Permeable Molecules for Targeting ProteinsMar 4, 2026 12:45:33 PM
Reducing Injection Site Pain in Vaccines: How Smarter Formulation Makes a DifferenceMar 3, 2026 9:09:04 PM
Ascendia Pharmaceutical Solutions to Meet With Drug Development Leaders at DCAT Week 2026Feb 12, 2026 2:58:16 PM
Ascendia Pharmaceutical Solutions to Present on Solubility and Bioavailability at CRBE Summit WestJan 30, 2026 1:36:31 PM
Nanotechnology in Oncology: Achieving Higher Payloads and Better Targeting with LipidSol®Jan 12, 2026 11:03:57 AM
Connect with Ascendia Pharmaceutical Solutions During JPM Week in San Francisco 2026Dec 2, 2025 11:58:52 AM
Ascendia Pharmaceutical Solutions Highlights Jim Huang’s Presentation at APV Mainz Seminar 2025Nov 19, 2025 2:23:14 PM